APO Research
Talk to an analyst

APO RESEARCH · REPORT

Embolotherapy

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Embolotherapy Market Analysis and Forecast 2026-2032

22 December 2025201 pages

Choose your research edition.

Industry ResearchEmbolotherapy Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Embolotherapy Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Embolotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Embolotherapy Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Embolotherapy Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Embolotherapy market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Embolotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Embolotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Embolotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Embolotherapy is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian and Stryker, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Embolotherapy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Embolotherapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Embolotherapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Embolotherapy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Embolotherapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Embolotherapy revenue, projected growth trends, production technology, application and end-user industry.

Embolotherapy Segment by Company

Medtronic

Boston Scientific

Terumo

Penumbra, Inc.

Johnson & Johnson

Sirtex

Merit Medical

Varian

Stryker

Jiangsu Hengrui Pharmaceuticals Co., Ltd

Cook Medical

Kaneka

Meril Life Sciences

Peijia Medical Limited

Wallaby Medical

MicroPort Scientific Corporation

Shandong Visee Medical Devices Co.,Ltd

Beijing Taijie Weiye Technology

Embolotherapy Segment by Type

Microspheres for Embolization

Embolism Particles

Embolic coils

Liquid Embolic Agent

Auxiliary Embolization Material

Others

Embolotherapy Segment by Application

Cancer

Peripheral Aascular Disease

Nerve System Disease

Others

Embolotherapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Embolotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolotherapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Embolotherapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Embolotherapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Embolotherapy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Embolotherapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Microspheres for Embolization Major Player Table 3. Embolism Particles Major Player Table 4. Embolic coils Major Player Table 5. Liquid Embolic Agent Major Player Table 6. Auxiliary Embolization Material Major Player Table 7. Others Major Player Table 8. Global Embolotherapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Cancer Major Player Table 10. Peripheral Aascular Disease Major Player Table 11. Nerve System Disease Major Player Table 12. Others Major Player Table 13. Embolotherapy Industry Trends Table 14. Embolotherapy Industry Drivers Table 15. Embolotherapy Industry Opportunities and Challenges Table 16. Embolotherapy Industry Restraints Table 17. Global Embolotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Embolotherapy Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Embolotherapy Market Share by Region (2021-2026) Table 20. Global Embolotherapy Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Embolotherapy Market Share by Region (2027-2032) Table 22. Global Embolotherapy Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Embolotherapy Revenue Market Share by Players (2021-2026) Table 24. Global Embolotherapy Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Embolotherapy Key Players Headquarters & Area Served Table 26. Global Embolotherapy Players, Product Type & Application Table 27. Global Embolotherapy Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Embolotherapy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Embolotherapy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Embolotherapy Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Embolotherapy Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Embolotherapy Revenue Market Share by Type (2021-2026) Table 34. Global Embolotherapy Revenue Market Share by Type (2027-2032) Table 35. Global Embolotherapy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Embolotherapy Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Embolotherapy Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Embolotherapy Revenue Market Share by Application (2021-2026) Table 39. Global Embolotherapy Revenue Market Share by Application (2027-2032) Table 40. Medtronic Company Information Table 41. Medtronic Business Overview Table 42. Medtronic Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Medtronic Embolotherapy Product Portfolio Table 44. Medtronic Recent Development Table 45. Boston Scientific Company Information Table 46. Boston Scientific Business Overview Table 47. Boston Scientific Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Boston Scientific Embolotherapy Product Portfolio Table 49. Boston Scientific Recent Development Table 50. Terumo Company Information Table 51. Terumo Business Overview Table 52. Terumo Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Terumo Embolotherapy Product Portfolio Table 54. Terumo Recent Development Table 55. Penumbra, Inc. Company Information Table 56. Penumbra, Inc. Business Overview Table 57. Penumbra, Inc. Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Penumbra, Inc. Embolotherapy Product Portfolio Table 59. Penumbra, Inc. Recent Development Table 60. Johnson & Johnson Company Information Table 61. Johnson & Johnson Business Overview Table 62. Johnson & Johnson Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Johnson & Johnson Embolotherapy Product Portfolio Table 64. Johnson & Johnson Recent Development Table 65. Sirtex Company Information Table 66. Sirtex Business Overview Table 67. Sirtex Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sirtex Embolotherapy Product Portfolio Table 69. Sirtex Recent Development Table 70. Merit Medical Company Information Table 71. Merit Medical Business Overview Table 72. Merit Medical Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Merit Medical Embolotherapy Product Portfolio Table 74. Merit Medical Recent Development Table 75. Varian Company Information Table 76. Varian Business Overview Table 77. Varian Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Varian Embolotherapy Product Portfolio Table 79. Varian Recent Development Table 80. Stryker Company Information Table 81. Stryker Business Overview Table 82. Stryker Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Stryker Embolotherapy Product Portfolio Table 84. Stryker Recent Development Table 85. Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information Table 86. Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview Table 87. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product Portfolio Table 89. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Development Table 90. Cook Medical Company Information Table 91. Cook Medical Business Overview Table 92. Cook Medical Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Cook Medical Embolotherapy Product Portfolio Table 94. Cook Medical Recent Development Table 95. Kaneka Company Information Table 96. Kaneka Business Overview Table 97. Kaneka Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Kaneka Embolotherapy Product Portfolio Table 99. Kaneka Recent Development Table 100. Meril Life Sciences Company Information Table 101. Meril Life Sciences Business Overview Table 102. Meril Life Sciences Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Meril Life Sciences Embolotherapy Product Portfolio Table 104. Meril Life Sciences Recent Development Table 105. Peijia Medical Limited Company Information Table 106. Peijia Medical Limited Business Overview Table 107. Peijia Medical Limited Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Peijia Medical Limited Embolotherapy Product Portfolio Table 109. Peijia Medical Limited Recent Development Table 110. Wallaby Medical Company Information Table 111. Wallaby Medical Business Overview Table 112. Wallaby Medical Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Wallaby Medical Embolotherapy Product Portfolio Table 114. Wallaby Medical Recent Development Table 115. MicroPort Scientific Corporation Company Information Table 116. MicroPort Scientific Corporation Business Overview Table 117. MicroPort Scientific Corporation Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. MicroPort Scientific Corporation Embolotherapy Product Portfolio Table 119. MicroPort Scientific Corporation Recent Development Table 120. Shandong Visee Medical Devices Co.,Ltd Company Information Table 121. Shandong Visee Medical Devices Co.,Ltd Business Overview Table 122. Shandong Visee Medical Devices Co.,Ltd Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product Portfolio Table 124. Shandong Visee Medical Devices Co.,Ltd Recent Development Table 125. Beijing Taijie Weiye Technology Company Information Table 126. Beijing Taijie Weiye Technology Business Overview Table 127. Beijing Taijie Weiye Technology Embolotherapy Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. Beijing Taijie Weiye Technology Embolotherapy Product Portfolio Table 129. Beijing Taijie Weiye Technology Recent Development Table 130. North America Embolotherapy Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Embolotherapy Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Embolotherapy Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Embolotherapy Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Embolotherapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Embolotherapy Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Embolotherapy Revenue by Country (US$ Million) & (2027-2032) Table 137. Europe Embolotherapy Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Embolotherapy Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Embolotherapy Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe Embolotherapy Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe Embolotherapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Embolotherapy Revenue by Country (2021-2026) & (US$ Million) Table 143. Europe Embolotherapy Revenue by Country (US$ Million) & (2027-2032) Table 144. China Embolotherapy Revenue by Type (2021-2026) & (US$ Million) Table 145. China Embolotherapy Revenue by Type (2027-2032) & (US$ Million) Table 146. China Embolotherapy Revenue by Application (2021-2026) & (US$ Million) Table 147. China Embolotherapy Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Embolotherapy Revenue by Type (2021-2026) & (US$ Million) Table 149. Asia Embolotherapy Revenue by Type (2027-2032) & (US$ Million) Table 150. Asia Embolotherapy Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Embolotherapy Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Embolotherapy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Embolotherapy Revenue by Region (US$ Million) & (2021-2026) Table 154. Asia Embolotherapy Revenue by Region (US$ Million) & (2027-2032) Table 155. SAMEA Embolotherapy Revenue by Type (2021-2026) & (US$ Million) Table 156. SAMEA Embolotherapy Revenue by Type (2027-2032) & (US$ Million) Table 157. SAMEA Embolotherapy Revenue by Application (2021-2026) & (US$ Million) Table 158. SAMEA Embolotherapy Revenue by Application (2027-2032) & (US$ Million) Table 159. SAMEA Embolotherapy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. SAMEA Embolotherapy Revenue by Country (2021-2026) & (US$ Million) Table 161. SAMEA Embolotherapy Revenue by Country (US$ Million) & (2027-2032) Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Embolotherapy Image Figure 2. Global Embolotherapy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Embolotherapy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Microspheres for Embolization Image Figure 5. Embolism Particles Image Figure 6. Embolic coils Image Figure 7. Liquid Embolic Agent Image Figure 8. Auxiliary Embolization Material Image Figure 9. Others Image Figure 10. Global Embolotherapy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Embolotherapy Market Size Share 2021 VS 2025 VS 2032 Figure 12. Cancer Image Figure 13. Peripheral Aascular Disease Image Figure 14. Nerve System Disease Image Figure 15. Others Image Figure 16. Global Embolotherapy Market Size (US$ Million) & (2021-2032) Figure 17. Global Embolotherapy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Embolotherapy Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Embolotherapy Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Embolotherapy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Embolotherapy Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Embolotherapy Revenue Market Share by Type (2021-2032) Figure 24. Global Embolotherapy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Embolotherapy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Embolotherapy Revenue Market Share by Application (2021-2032) Figure 27. North America Embolotherapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Embolotherapy Revenue Share by Type (2021-2032) Figure 29. North America Embolotherapy Revenue Share by Application (2021-2032) Figure 30. North America Embolotherapy Revenue Share by Country (2021-2032) Figure 31. United States Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Embolotherapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Embolotherapy Revenue Share by Type (2021-2032) Figure 36. Europe Embolotherapy Revenue Share by Application (2021-2032) Figure 37. Europe Embolotherapy Revenue Share by Country (2021-2032) Figure 38. Germany Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Embolotherapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Embolotherapy Revenue Share by Type (2021-2032) Figure 48. China Embolotherapy Revenue Share by Application (2021-2032) Figure 49. Asia Embolotherapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Embolotherapy Revenue Share by Type (2021-2032) Figure 51. Asia Embolotherapy Revenue Share by Application (2021-2032) Figure 52. Asia Embolotherapy Revenue Share by Region (2021-2032) Figure 53. Japan Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Embolotherapy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Embolotherapy Revenue Share by Type (2021-2032) Figure 61. SAMEA Embolotherapy Revenue Share by Application (2021-2032) Figure 62. SAMEA Embolotherapy Revenue Share by Country (2021-2032) Figure 63. Brazil Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Embolotherapy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Microspheres for Embolization
  • Embolism Particles
  • Embolic coils
  • Liquid Embolic Agent
  • Auxiliary Embolization Material
  • Others
Applications
  • Cancer
  • Peripheral Aascular Disease
  • Nerve System Disease
  • Others
Companies covered
  • Medtronic
  • Boston Scientific
  • Terumo
  • Penumbra, Inc.
  • Johnson & Johnson
  • Sirtex
  • Merit Medical
  • Varian
  • Stryker
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd
  • Cook Medical
  • Kaneka
  • Meril Life Sciences
  • Peijia Medical Limited
  • Wallaby Medical
  • MicroPort Scientific Corporation
  • Shandong Visee Medical Devices Co.,Ltd
  • Beijing Taijie Weiye Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Embolotherapy Market by Type
  3. 1.2.1 Global Embolotherapy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Microspheres for Embolization
  5. 1.2.3 Embolism Particles
  6. 1.2.4 Embolic coils
  7. 1.2.5 Liquid Embolic Agent
  8. 1.2.6 Auxiliary Embolization Material
  9. 1.2.7 Others
  10. 1.3 Embolotherapy Market by Application
  11. 1.3.1 Global Embolotherapy Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Cancer
  13. 1.3.3 Peripheral Aascular Disease
  14. 1.3.4 Nerve System Disease
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Embolotherapy Market Dynamics
  1. 2.1 Embolotherapy Industry Trends
  2. 2.2 Embolotherapy Industry Drivers
  3. 2.3 Embolotherapy Industry Opportunities and Challenges
  4. 2.4 Embolotherapy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Embolotherapy Market Perspective (2021-2032)
  2. 3.2 Global Embolotherapy Growth Trends by Region
  3. 3.2.1 Global Embolotherapy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Embolotherapy Market Size by Region (2021-2026)
  5. 3.2.3 Global Embolotherapy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Embolotherapy Revenue by Players
  2. 4.1.1 Global Embolotherapy Revenue by Players (2021-2026)
  3. 4.1.2 Global Embolotherapy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Embolotherapy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Embolotherapy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Embolotherapy Key Players Headquarters & Area Served
  7. 4.4 Global Embolotherapy Players, Product Type & Application
  8. 4.5 Global Embolotherapy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Embolotherapy Market CR5 and HHI
  11. 4.6.3 2025 Embolotherapy Tier 1, Tier 2, and Tier 3
5 Embolotherapy Market Size by Type
  1. 5.1 Global Embolotherapy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Embolotherapy Revenue by Type (2021-2032)
  3. 5.3 Global Embolotherapy Revenue Market Share by Type (2021-2032)
6 Embolotherapy Market Size by Application
  1. 6.1 Global Embolotherapy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Embolotherapy Revenue by Application (2021-2032)
  3. 6.3 Global Embolotherapy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Medtronic
  2. 7.1.1 Medtronic Company Information
  3. 7.1.2 Medtronic Business Overview
  4. 7.1.3 Medtronic Embolotherapy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Medtronic Embolotherapy Product Portfolio
  6. 7.1.5 Medtronic Recent Developments
  7. 7.2 Boston Scientific
  8. 7.2.1 Boston Scientific Company Information
  9. 7.2.2 Boston Scientific Business Overview
  10. 7.2.3 Boston Scientific Embolotherapy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Boston Scientific Embolotherapy Product Portfolio
  12. 7.2.5 Boston Scientific Recent Developments
  13. 7.3 Terumo
  14. 7.3.1 Terumo Company Information
  15. 7.3.2 Terumo Business Overview
  16. 7.3.3 Terumo Embolotherapy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Terumo Embolotherapy Product Portfolio
  18. 7.3.5 Terumo Recent Developments
  19. 7.4 Penumbra, Inc.
  20. 7.4.1 Penumbra, Inc. Company Information
  21. 7.4.2 Penumbra, Inc. Business Overview
  22. 7.4.3 Penumbra, Inc. Embolotherapy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Penumbra, Inc. Embolotherapy Product Portfolio
  24. 7.4.5 Penumbra, Inc. Recent Developments
  25. 7.5 Johnson & Johnson
  26. 7.5.1 Johnson & Johnson Company Information
  27. 7.5.2 Johnson & Johnson Business Overview
  28. 7.5.3 Johnson & Johnson Embolotherapy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Johnson & Johnson Embolotherapy Product Portfolio
  30. 7.5.5 Johnson & Johnson Recent Developments
  31. 7.6 Sirtex
  32. 7.6.1 Sirtex Company Information
  33. 7.6.2 Sirtex Business Overview
  34. 7.6.3 Sirtex Embolotherapy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sirtex Embolotherapy Product Portfolio
  36. 7.6.5 Sirtex Recent Developments
  37. 7.7 Merit Medical
  38. 7.7.1 Merit Medical Company Information
  39. 7.7.2 Merit Medical Business Overview
  40. 7.7.3 Merit Medical Embolotherapy Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Merit Medical Embolotherapy Product Portfolio
  42. 7.7.5 Merit Medical Recent Developments
  43. 7.8 Varian
  44. 7.8.1 Varian Company Information
  45. 7.8.2 Varian Business Overview
  46. 7.8.3 Varian Embolotherapy Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Varian Embolotherapy Product Portfolio
  48. 7.8.5 Varian Recent Developments
  49. 7.9 Stryker
  50. 7.9.1 Stryker Company Information
  51. 7.9.2 Stryker Business Overview
  52. 7.9.3 Stryker Embolotherapy Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Stryker Embolotherapy Product Portfolio
  54. 7.9.5 Stryker Recent Developments
  55. 7.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
  56. 7.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
  57. 7.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
  58. 7.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product Portfolio
  60. 7.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments
  61. 7.11 Cook Medical
  62. 7.11.1 Cook Medical Company Information
  63. 7.11.2 Cook Medical Business Overview
  64. 7.11.3 Cook Medical Embolotherapy Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Cook Medical Embolotherapy Product Portfolio
  66. 7.11.5 Cook Medical Recent Developments
  67. 7.12 Kaneka
  68. 7.12.1 Kaneka Company Information
  69. 7.12.2 Kaneka Business Overview
  70. 7.12.3 Kaneka Embolotherapy Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Kaneka Embolotherapy Product Portfolio
  72. 7.12.5 Kaneka Recent Developments
  73. 7.13 Meril Life Sciences
  74. 7.13.1 Meril Life Sciences Company Information
  75. 7.13.2 Meril Life Sciences Business Overview
  76. 7.13.3 Meril Life Sciences Embolotherapy Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Meril Life Sciences Embolotherapy Product Portfolio
  78. 7.13.5 Meril Life Sciences Recent Developments
  79. 7.14 Peijia Medical Limited
  80. 7.14.1 Peijia Medical Limited Company Information
  81. 7.14.2 Peijia Medical Limited Business Overview
  82. 7.14.3 Peijia Medical Limited Embolotherapy Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Peijia Medical Limited Embolotherapy Product Portfolio
  84. 7.14.5 Peijia Medical Limited Recent Developments
  85. 7.15 Wallaby Medical
  86. 7.15.1 Wallaby Medical Company Information
  87. 7.15.2 Wallaby Medical Business Overview
  88. 7.15.3 Wallaby Medical Embolotherapy Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Wallaby Medical Embolotherapy Product Portfolio
  90. 7.15.5 Wallaby Medical Recent Developments
  91. 7.16 MicroPort Scientific Corporation
  92. 7.16.1 MicroPort Scientific Corporation Company Information
  93. 7.16.2 MicroPort Scientific Corporation Business Overview
  94. 7.16.3 MicroPort Scientific Corporation Embolotherapy Revenue and Gross Margin (2021-2026)
  95. 7.16.4 MicroPort Scientific Corporation Embolotherapy Product Portfolio
  96. 7.16.5 MicroPort Scientific Corporation Recent Developments
  97. 7.17 Shandong Visee Medical Devices Co.,Ltd
  98. 7.17.1 Shandong Visee Medical Devices Co.,Ltd Company Information
  99. 7.17.2 Shandong Visee Medical Devices Co.,Ltd Business Overview
  100. 7.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product Portfolio
  102. 7.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Developments
  103. 7.18 Beijing Taijie Weiye Technology
  104. 7.18.1 Beijing Taijie Weiye Technology Company Information
  105. 7.18.2 Beijing Taijie Weiye Technology Business Overview
  106. 7.18.3 Beijing Taijie Weiye Technology Embolotherapy Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Beijing Taijie Weiye Technology Embolotherapy Product Portfolio
  108. 7.18.5 Beijing Taijie Weiye Technology Recent Developments
8 North America
  1. 8.1 North America Embolotherapy Revenue (2021-2032)
  2. 8.2 North America Embolotherapy Revenue by Type (2021-2032)
  3. 8.2.1 North America Embolotherapy Revenue by Type (2021-2026)
  4. 8.2.2 North America Embolotherapy Revenue by Type (2027-2032)
  5. 8.3 North America Embolotherapy Revenue Share by Type (2021-2032)
  6. 8.4 North America Embolotherapy Revenue by Application (2021-2032)
  7. 8.4.1 North America Embolotherapy Revenue by Application (2021-2026)
  8. 8.4.2 North America Embolotherapy Revenue by Application (2027-2032)
  9. 8.5 North America Embolotherapy Revenue Share by Application (2021-2032)
  10. 8.6 North America Embolotherapy Revenue by Country
  11. 8.6.1 North America Embolotherapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Embolotherapy Revenue by Country (2021-2026)
  13. 8.6.3 North America Embolotherapy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Embolotherapy Revenue (2021-2032)
  2. 9.2 Europe Embolotherapy Revenue by Type (2021-2032)
  3. 9.2.1 Europe Embolotherapy Revenue by Type (2021-2026)
  4. 9.2.2 Europe Embolotherapy Revenue by Type (2027-2032)
  5. 9.3 Europe Embolotherapy Revenue Share by Type (2021-2032)
  6. 9.4 Europe Embolotherapy Revenue by Application (2021-2032)
  7. 9.4.1 Europe Embolotherapy Revenue by Application (2021-2026)
  8. 9.4.2 Europe Embolotherapy Revenue by Application (2027-2032)
  9. 9.5 Europe Embolotherapy Revenue Share by Application (2021-2032)
  10. 9.6 Europe Embolotherapy Revenue by Country
  11. 9.6.1 Europe Embolotherapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Embolotherapy Revenue by Country (2021-2026)
  13. 9.6.3 Europe Embolotherapy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Embolotherapy Revenue (2021-2032)
  2. 10.2 China Embolotherapy Revenue by Type (2021-2032)
  3. 10.2.1 China Embolotherapy Revenue by Type (2021-2026)
  4. 10.2.2 China Embolotherapy Revenue by Type (2027-2032)
  5. 10.3 China Embolotherapy Revenue Share by Type (2021-2032)
  6. 10.4 China Embolotherapy Revenue by Application (2021-2032)
  7. 10.4.1 China Embolotherapy Revenue by Application (2021-2026)
  8. 10.4.2 China Embolotherapy Revenue by Application (2027-2032)
  9. 10.5 China Embolotherapy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Embolotherapy Revenue (2021-2032)
  2. 11.2 Asia Embolotherapy Revenue by Type (2021-2032)
  3. 11.2.1 Asia Embolotherapy Revenue by Type (2021-2026)
  4. 11.2.2 Asia Embolotherapy Revenue by Type (2027-2032)
  5. 11.3 Asia Embolotherapy Revenue Share by Type (2021-2032)
  6. 11.4 Asia Embolotherapy Revenue by Application (2021-2032)
  7. 11.4.1 Asia Embolotherapy Revenue by Application (2021-2026)
  8. 11.4.2 Asia Embolotherapy Revenue by Application (2027-2032)
  9. 11.5 Asia Embolotherapy Revenue Share by Application (2021-2032)
  10. 11.6 Asia Embolotherapy Revenue by Country
  11. 11.6.1 Asia Embolotherapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Embolotherapy Revenue by Country (2021-2026)
  13. 11.6.3 Asia Embolotherapy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Embolotherapy Revenue (2021-2032)
  2. 12.2 SAMEA Embolotherapy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Embolotherapy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Embolotherapy Revenue by Type (2027-2032)
  5. 12.3 SAMEA Embolotherapy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Embolotherapy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Embolotherapy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Embolotherapy Revenue by Application (2027-2032)
  9. 12.5 SAMEA Embolotherapy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Embolotherapy Revenue by Country
  11. 12.6.1 SAMEA Embolotherapy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Embolotherapy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Embolotherapy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst